Ms Amy Kate Searle

Biography

Amy first joined the Baker Heart and Diabetes Institute in 2014, when she completed her Bachelor of Biomedical Science (Honours) with Professor Alex Bobik and the School of Life Sciences at Deakin University. Amy was awarded First Class Honours for her work on TCR gamma delta T cells and their role in atherosclerosis. Prior to this, she received a tuition scholarship to complete a portion of her undergraduate studies at State University New York (SUNY) Stony Brook, in the USA. At the completion of her undergraduate studies, Amy received an invitation to the Golden Key International Honour Society for outstanding academic achievements and she was also awarded the Global Citizen Award, a prestigious Deakin University award given for active involvement in global study and professional experiences. Following the completion of her minor thesis, Amy worked as a Research Assistant within the Atherothrombosis and Vascular Biology laboratory at the Baker Heart and Diabetes Institute, where she assisted two post-doctoral researchers with a focus on unstable plaques and the utilisation of imaging modalities for theranostic (simultaneously therapeutic and diagnostic) applications towards cardiovascular diseases. Amy found her love for research and is currently a PhD student within the Atherothrombosis and Vascular Biology laboratory through the Central Clinical School at Monash University. Based on her previous research exposure, she developed a keen interest for theranostics and her PhD project aims to develop a targeted diagnostic/therapeutic approach to provide novel treatment for thrombotic and cardiovascular diseases. Amy believes that her research has the potential to impact upon the mortality associated with cardiovascular diseases, to a point where one day, heart attack and stroke may not be our biggest global killer. Amy is co-supervised by Professor Karlheinz Peter and Dr Xiaowei Wang.

Research Interest

Atherothrombosis and Vascular Biology